Vivimed Labs Ltd

VIVIMEDLAB
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹167 cr, stock is ranked 1,841
High RiskStock is 4.87x as volatile as Nifty
20.250.25 (+1.25%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹167 cr, stock is ranked 1,841
High RiskStock is 4.87x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-2.16
PB RatioPB Ratio
0.20
Dividend YieldDiv. Yield
Sector PESector PE
24.30
Sector PBSector PB
3.09
Sector Div YldSctr Div Yld
1.59%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Vivimed Labs Limited makes active ingredients for a range of home, personal care and industrial products and is engaged in contractual manufacturing for active pharmaceutical ingredient and contract manufacturing of formulations for generic companies

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020211.201.341.070.870.080.06-0.11-0.08
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Reply to Clarification Sought 
Announced OnJan 24, 2022

VIVIMEDLAB: The Exchange had sought clarification from Vivimed Labs Limited with respect to announcement dated 10-Jan-2022, regarding Resignation of Mrs. Umanath Varahabhotla as Independent Director of the company w.e.f. January 10, 2022. On basis of above the Company was required to clarify following: 1. Confirmation from the resigning director that there are no other material reasons other than provided; 2. ᅡᅠThe Letter of resignation of the independent director mentioning the detailed reasons for the resignation; 3. Names of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of board committees, if any. The response of the Company is attached. | Download

VIVIMEDLAB: The Exchange had sought clarification from Vivimed Labs Limited with respect to announcement dated 10-Jan-2022, regarding Resignation of Mrs. Umanath Varahabhotla as Independent Director of the company w.e.f. January 10, 2022. On basis of above the Company was required to clarify following: 1. Confirmation from the resigning director that there are no other material reasons other than provided; 2. ᅡᅠThe Letter of resignation of the independent director mentioning the detailed reasons for the resignation; 3. Names of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of board committees, if any. The response of the Company is attached. | Download

Clarification 
Announced OnJan 18, 2022
VIVIMEDLAB: The Exchange has sought clarification from Vivimed Labs Limited with respect to announcement dated 10-Jan-2022, regarding Resignation of Mrs. Umanath Varahabhotla as Independent Director of the company w.e.f. January 10, 2022. On basis of above the Company is required to clarify following: 1. Confirmation from the resigning director that there are no other material reasons other than provided; 2. ᅡᅠThe Letter of resignation of the independent director mentioning the detailed reasons for the resignation; 3. Names of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of board committees, if any. The response of the Company is awaited.
VIVIMEDLAB: The Exchange has sought clarification from Vivimed Labs Limited with respect to announcement dated 10-Jan-2022, regarding Resignation of Mrs. Umanath Varahabhotla as Independent Director of the company w.e.f. January 10, 2022. On basis of above the Company is required to clarify following: 1. Confirmation from the resigning director that there are no other material reasons other than provided; 2. ᅡᅠThe Letter of resignation of the independent director mentioning the detailed reasons for the resignation; 3. Names of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of board committees, if any. The response of the Company is awaited.
Cash Dividend 
Ex. DateSep 19, 2018

Final • Div/Share: ₹ 0.4

See all events